Publications by authors named "Wendy London"

Claim this Profile
S
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.
Florette K Hazard, Angus M S Toland, Serena Y Tan, Bill Chiu, Naohiko Ikegaki, Wendy B London

Clin Cancer Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the Incidence of Hypercalcemia in Contemporary Diagnoses of Pediatric Patients With Solid Tumors.
Felicia Y Ho, Dajana Alku, Chalinee Monsereenusorn, Nan Chen, Wendy B London

Pediatr Blood Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors.
David S Shulman, Kieuhoa T Vo, Frank M Balis, Holly Lindsay, Rochelle Bagatell, Wendy B London

Cancer Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project.
Wendy B London, Gabriela Villanueva, Derek Shyr, Jaques van Heerden, Soad Fuentes-Alabi

JCO Glob Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project.
Mallory R Taylor, James R Anderson, Julie R Park, Meredith S Irwin, Mark A Applebaum, Wendy B London

Pediatr Blood Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group.
Tara O Henderson, Jenna K Bardwell, Pei-Chi Kao, Paul C Nathan, Wendy Landier, Wendy B London

Lancet Child Adolesc Health· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.
Kristin A Shimano, Amanda B Grimes, Shipra Kaicker, Sanjay J Shah, Elizabeth Gunn, Wendy B London

JAMA· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histologic Response to Induction Chemotherapy in High-Risk Neuroblastoma.
Monica Pomaville, Pei-Chi Kao, Antonio Perez-Atayde, Wendy B London, Rani E George

Cancer Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome.
Asaf Maoz, Nan Chen, Puja Umaretiya, Sophie R Cahill, Alison Schwartz-Levine, Wendy B London

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group.
Hetal Dholaria, Arlene Naranjo, Fan F Zhang, Wendy B London, Lisa Diller

Pediatr Blood Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International neuroblastoma risk group consortium: a model of a networking for rare cancers.
Susan L Cohn, Wendy B London, Gudrun Schleiermacher, Lucas Moreno, Inge M Ambros

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
Erin G Brown, E Stanton Adkins, Peter Mattei, Fredric A Hoffer, Sandra L Wootton-Gorges, Wendy B London

J Pediatr Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the Diagnosis of Pediatric Venous Thromboembolism and Arterial Ischemic Stroke during the COVID-19 Pandemic: An Administrative Database Study.
Riten Kumar, Nan Chen, Laura L Lehman, Wendy B London

J Pediatr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531.
Julie Voeller, Howard M Katzenstein, Arlene Naranjo, Sheena C Tenney, Lulu Chen, Wendy B London

Pediatr Blood Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.
Mary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, Jayne Vogelzang, Cecilia Sousa, Wendy B London

Neuro Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology.
Hannah E Olsen, Pei-Chi Kao, Caleb Richmond, David S Shulman, Wendy B London

Cancer Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted-Agent Continual Reassessment Method: A Novel Bayesian Enrichment Design for Phase I Trials of Molecularly Targeted Therapies.
Clement Ma, David S Shulman, Hasan Al-Sayegh, Steven G DuBois, Wendy B London

JCO Precis Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in Children's Oncology Group neuroblastoma risk stratification through a change in age cut-off and use of INRGSS.
Wendy B London, Hannah Bousquet, Meredith S Irwin, Michael D Hogarty, Susan L Cohn

Transl Pediatr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Erin K Barr, Arlene Naranjo, Clare J Twist, Sheena C Tenney, Mary Lou Schmidt, Wendy B London

Pediatr Blood Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
Suzanne J Forrest, Hersh Gupta, Abigail Ward, Yvonne Y Li, Duong Doan, Wendy B London

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
Suzanne J Forrest, Hersh Gupta, Abigail Ward, Yvonne Y Li, Duong Doan, Wendy B London

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter study.
Elena B Hawryluk, Danna Moustafa, Kelly K Barry, Eman Bahrani, Diana B Reusch, Wendy B London

J Am Acad Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy.
Michelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, Nan Chen, Sonata Jodele, Wendy B London

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma.
Kevin Campbell, Andrew Posner, Nan Chen, Kerri Cavanaugh, Ketki Bhushan, Wendy B London

Pediatr Blood Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monte Carlo based dosimetry of extraoral photobiomodulation for prevention of oral mucositis.
Anna N Yaroslavsky, Tyler W Iorizzo, Amy F Juliano, Ather Adnan, James D Carroll, Wendy B London

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis